Tizanidine Tablet
Product Images NDC 71335-1799

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-1799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure diagram of Tizanidine hydrochloride showing its molecular framework with rings and functional groups, including a chlorine atom and nitrogen-containing heterocycles.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A line graph showing plasma Tizanidine concentration (ng/mL) over time in hours from dosing. The graph compares four conditions: 4 mg Tizanidine tablets and capsules taken with and without food. Concentration peaks occur within a few hours post-dose, followed by a gradual decline to near zero by 24 hours.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph showing improvement in Ashworth score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The graph plots mean scores with error bars, indicating greater improvement with the 16 mg dose compared to 8 mg and placebo across the time points.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A line graph showing improvement in Ashworth Score over time points (End of Titration, End of Maintenance, Endpoint) comparing tizanidine (mean dose 28.8 mg) and placebo groups. The y-axis represents improvement, with tizanidine data points lower on the scale, indicating greater improvement versus placebo. Error bars reflect variability at each time point.*

FDA Label Image

Label (Lbl713351799)

Tizanidine 2 mg tablet label from Bryant Ranch Prepack. The label states it is comparable to Zanaflex 2 mg tablets by ALKALOIDA chemical company Zrt. It includes storage instructions to keep at 20-25°C, a warning about dizziness or drowsiness, and features an NDC number 71335-1799-1. The package contains 30 tablets and is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.